|
| Press Releases |
|
 |
|
| Friday, May 7, 2021 |
|
|
아방스 클리니컬, 174억 달러 규모 시장 수요를 충족하는 유전 기술 임상 시험 서비스 확대 |
| 호주의 바이오테크 임상수탁기관(CRO) 선두주자이자 프로스트&설리번(Frost & Sullivan)이 수여하는 아시아-태평양 CRO 마켓 리더십 어워드(Asia-Pacific CRO Market Leadership Award)를 수상한 바 있는 아방스 클리니컬은 2023년까지 174억 달러 규모로 증가할 것으로 예상되는 글로벌 수요를 충족할 수 있도록 유전 기술 임상 시험 서비스를 확대해 왔다. more info >> |
|
|
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion by 2023. more info >> |
|
| Friday, April 23, 2021 |
|
|
Avance Clinical社がOracle Health Sciences Connectで「Decentralized Trials - No Going Back」と題した講演に招待されました |
| オーストラリアを代表するバイオテクノロジー企業向けCROであり、フロスト＆サリバン社のアジア太平洋CROマーケット・リーダーシップ・アワードを受賞したアヴァンス・クリニカルは、オラクル・ヘルス・サイエンス・コネクト・カンファレンスに招待され、分散型臨床試験の未来について発表しました。 more info >> |
|
|
아방스 클리니컬, 오라클 헬스 사이언스 커넥트에 초청되어 "분산형 실험 - 이전으로 돌아갈 수 없는 획기적 발전" 발표 |
| 호주의 바이오테크 임상수탁기관(CRO)선두주자이자 프로스트&설리번(Frost & Sullivan)이 수여하는 아시아태평양 CRO 마켓 리더십 어워드(Asia-Pacific CRO Market Leadership Award)를 수상한 바 있는 아방스 클리니컬은 오라클 헬스 사이언스 커넥트 컨퍼런스에 초청받아 분산형 임상실험(decentralized clinical trials, DCT)의 미래에 대해 발표했다. more info >> |
|
| Thursday, April 22, 2021 |
|
|
Avance Clinical受邀發表“分散試驗–不再回頭” 適用於Oracle Health Sciences Connect |
| 澳大利亞領先的生物技術CRO和Frost＆Sullivan亞太CRO市場領導獎獲得者Avance Clinical已應邀在Oracle Health Sciences Connect會議上介紹了分散臨床試驗的未來。 more info >> |
|
|
Avance Clinical受邀发表“分散试验–不再回头” 适用于Oracle Health Sciences Connect |
| 澳大利亚领先的生物技术CRO和Frost＆Sullivan亚太CRO市场领导奖获得者Avance Clinical已应邀在Oracle Health Sciences Connect会议上介绍了分散临床试验的未来。 more info >> |
|
|
Avance Clinical Invited to Present "Decentralized Trials - No Going Back" for Oracle Health Sciences Connect |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. more info >> |
|
| Friday, March 12, 2021 |
|
|
Avance臨床客戶Atossa Therapeutics宣布了第一階段臨床研究的最終結果，該研究表明針對COVID-19研發的AT-301鼻噴霧劑的安全性和耐受性 |
澳大利亞領先的生物技術CRO和Frost＆Sullivan亞太CRO市場領導獎獲得者Avance Clinical祝賀Atossa Therapeutics宣布了他們為COVID-19開發的AT-301鼻噴霧劑的第一階段最終結果。
more info >> |
|
|
Avance临床客户Atossa Therapeutics宣布了第一阶段临床研究的最终结果，该研究表明针对COVID-19研发的AT-301鼻喷雾剂的安全性和耐受性 |
| more info >> |
|
|
Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19 |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
全球最大一站式珠寶商貿平台匯聚約80,000名買家 東盟、韓國等地買家見增長
Mar 8, 2026 20:04 HKT/SGT
|
|
|
全球最大一站式珠宝商贸平台汇聚约80,000名买家 东盟、韩国等地买家见增长
Mar 8, 2026 20:04 HKT/SGT
|
|
|
Shareholder-Exclusive Benefit! Shoucheng Holdings Launches Exclusive Entry Slots for Shareholders in the "2026 Beijing Yizhuang Half Marathon'' - Robot Marathon Becomes a New Carrier for Shareholder Benefits
Mar 8, 2026 18:00 HKT/SGT
|
|
|
股东专属福利！首程控股推出"2026北京亦庄半马"股东专属参赛名额 机器人马拉松成股东福利新载体
Mar 8, 2026 18:00 HKT/SGT
|
|
|
股東專屬福利：首程控股推出「2026北京亦莊半馬」股東專屬參賽名額 機器人馬拉松成股東福利新載體
Mar 8, 2026 18:00 HKT/SGT
|
|
|
Hong Kong Completes First Green Methanol Bunkering, Driving Green Transformation of Its International Shipping Hub
Mar 8, 2026 16:05 JST
|
|
|
International Women's Day: Why Menopause May Be a Missed Cardiovascular Risk Window
Mar 6, 2026 20:00 JST
|
|
|
Xunce (3317.HK) Released Profit Alert: Revenue Doubles, Surpasses Expectations by a Wide Margin, China's Palantir Rises!
Mar 6, 2026 18:23 HKT/SGT
|
|
|
迅策(3317.HK)發佈盈利預告：營收翻翻 大超預期 中國版Palantir崛起！
Mar 6, 2026 18:17 HKT/SGT
|
|
|
迅策(3317.HK)发布盈利预告：营收翻翻 大超预期 中国版Palantir崛起！
Mar 6, 2026 18:00 HKT/SGT
|
|
|
香港實現綠色甲醇首船加注 推動國際航運中心綠色轉型
Mar 6, 2026 15:40 HKT/SGT
|
|
|
香港实现绿色甲醇首船加注 推动国际航运中心绿色转型
Mar 6, 2026 15:31 HKT/SGT
|
|
|
Hong Kong Tech Innovators Drive Success at Mobile World Congress and 4YFN Barcelona 2026
Mar 6, 2026 13:08 HKT/SGT
|
|
|
U.S. Polo Assn. Expands Collegiate Partnership Program to Record 70 Teams for 2026 Season
Mar 6, 2026 12:12 HKT/SGT
|
|
|
Anime Tokyo Station: "That Time I Got Reincarnated as a Slime" Special Exhibition, February 21 to May 24, 2026
Mar 6, 2026 10:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
